Skip to content
Bamboo Works
Search
Register / Sign in
MSCI China | MSCI China Small-Cap | Hang Seng Index | Hang Seng China Enterprise
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Premium Content
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Premium Content
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

R&D costs

FAST NEWS: InnoCare inches closer to profitability on strong sales gains

The latest: InnoCare Pharma Ltd. (9969.HK) announced Tuesday its first-quarter revenue jumped 59% year-over-year to 189 million yuan ($27.3 million), while its net loss narrowed 90% to 12.41 million yuan. Looking…
May 10, 2023
9969.HK

FAST NEWS: Kintor Pharma hits new low as loss keeps growing

The latest: Kintor Pharmaceutical Ltd. (9939.HK) announced on Thursday it did not record any revenue last year, as its net loss widened 13.3% to 954 million yuan ($139 million) from 842 million…
March 31, 2023
9939.HK

FAST NEWS: BeiGene Loss Narrows on Brisk Sales for Core Products

The latest: Cancer drug maker BeiGene Ltd. (BGNE.US; 6160.HK; 668235.SH) announced Monday its revenue rose 20.4% last year to $1.42 billion, thanks to big increases from its two core products,…
February 28, 2023
6160.HK

FAST NEWS: InnoCare Pharma’s Loss Soars on R&D Costs, Exchange Losses

The latest: InnoCare Pharma Ltd. (9969.HK) said it expects to report its net loss soared about 13 times to 910 million yuan ($134 million) last year, according to a profit…
January 30, 2023

FAST NEWS: InnoCare Pharma Losses Double on Higher Costs And Exchange Deficit

The latest: InnoCare Pharma Ltd. (9969.HK) issued a profit warning Friday, estimating a net loss of no more than 495 million yuan ($73 million) for the first half of this year,…
August 5, 2022

Recent Articles

May 10, 2023

FAST NEWS: InnoCare inches closer to profitability on strong sales gains

9969.HK
March 31, 2023

FAST NEWS: Kintor Pharma hits new low as loss keeps growing

9939.HK
February 28, 2023

FAST NEWS: BeiGene Loss Narrows on Brisk Sales for Core Products

6160.HK
January 30, 2023

FAST NEWS: InnoCare Pharma’s Loss Soars on R&D Costs, Exchange Losses

August 5, 2022

FAST NEWS: InnoCare Pharma Losses Double on Higher Costs And Exchange Deficit

RELATED ARTICLES

  1. January 17, 2025
    BRIEF: InnoCare revenue jumps 37% in 2024 on strong lymphoma drug sales
    9969.HK 688428.SHG
  2. April 3, 2025
    After 14 years of losses, Zhihu finds an answer to its profitability question
    2390.HK ZH.US
  3. January 24, 2025
    Lopal steers back towards profitability after tough two years
    2465.HK 603906.SHG
  4. March 10, 2025
    Cango gets crypto jolt back to revenue growth, profitability
    CANG.US
  5. November 13, 2024
    BitFuFu makes big gains as cryptocurrency booms
    FUFU.US
  6. January 21, 2025
    BRIEF: InnoCare, KeyMed in antibody licensing agree with Prolium
    9969.HK 688428.SHG
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Premium Content
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2024 Bamboo Works. All rights reserved.